The manipulation of ADXS is one for the books. Rarely do you see such a disconnect between a share price and the progress of a company. This would not have continued for so long and to such an extent if not for the coincidental timing of both the baseless FDA hold and the ensuing biotech meltdown. But I am fairly convinced that they are now substantially trapped.
News 
Market Data 
Discover 
